13 March 2020
Visiongain has launched a new pharma report: Global Live Vaccines Market Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.
Live attenuated vaccines contain weakened versions of the live virus to create a protective immune response in healthy individuals. They include vaccines for measles, mumps and rubella (MMR), varicella (chickenpox), Oral Polio Vaccine (OPV) etc. The resurgence of interest in vaccine research has been underpinned by the rapidly expanding body of knowledge in the fields of microbial pathogenesis and immunology. This has advanced the ability of researchers and manufacturers to create both preventive and therapeutic vaccines and target new diseases.
The lead analyst of the report commented "There are a number of innovative vaccines in the pipeline, which will enter the market in the coming decade. Advancements in technology will lead to improvements in the efficacy & coverage of vaccines. The recent rise in global disease outbreaks such as Ebola, Zika, Nipah and 1N1 virus has further increased demand for vaccines and galvanised vaccine advocacy. The Asia Pacific region will be the fastest growing submarket, due to a rise in governments implementing national immunisation policies & public awareness initiatives by organisations like WHO."
Leading companies featured in the report include AstraZeneca, Bavarian Nordic A/S, DAIICHI SANKYO COMPANY, LIMITED, Emergent BioSolutions Inc., GlaxoSmithKline plc, Inovio Pharmaceuticals, Inc. & Other Companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.